Trial intelligence / Profile preview

Lemborexant for insomnia disorder in Chinese adults

CTR20190248Phase 3Completed

Sponsor
Eisai Co., Ltd.
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd.. Started Aug 2020; status: completed.

02

Drugs

lemborexant
03

Conditions

Insomnia

Beyond the preview

Go deeper on CTR20190248.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190248.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call